Maravai LifeSciences Holdings Total Current Liabilities 2019-2025 | MRVI
Maravai LifeSciences Holdings total current liabilities from 2019 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Maravai LifeSciences Holdings Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $57 |
| 2023 | $87 |
| 2022 | $110 |
| 2021 | $94 |
| 2020 | $131 |
| 2019 | $30 |
| 2018 | $36 |
| Maravai LifeSciences Holdings Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $63 |
| 2024-12-31 | $57 |
| 2024-09-30 | $63 |
| 2024-06-30 | $69 |
| 2024-03-31 | $59 |
| 2023-12-31 | $87 |
| 2023-09-30 | $78 |
| 2023-06-30 | $75 |
| 2023-03-31 | $125 |
| 2022-12-31 | $110 |
| 2022-09-30 | $116 |
| 2022-06-30 | $113 |
| 2022-03-31 | $87 |
| 2021-12-31 | $94 |
| 2021-09-30 | $114 |
| 2021-06-30 | $165 |
| 2021-03-31 | $165 |
| 2020-12-31 | $131 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $30 |
| 2018-12-31 | $36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.644B | $0.259B |
| Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
| Boston Scientific (BSX) | United States | $152.620B | 38.21 |
| Stryker (SYK) | United States | $150.824B | 31.54 |
| EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
| Medtronic (MDT) | Ireland | $117.545B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
| ResMed (RMD) | United States | $39.208B | 29.45 |
| GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
| Agilent Technologies (A) | United States | $33.005B | 21.52 |
| Koninklijke Philips (PHG) | Netherlands | $24.092B | 16.91 |
| Terumo (TRUMY) | Japan | $23.645B | 30.71 |
| Insulet (PODD) | United States | $20.097B | 78.89 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
| Baxter (BAX) | United States | $14.117B | 10.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
| Lantheus Holdings (LNTH) | United States | $5.005B | 12.62 |
| Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Haemonetics (HAE) | United States | $3.565B | 16.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.397B | 28.23 |
| ICU Medical (ICUI) | United States | $3.107B | 22.91 |
| LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
| QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
| AtriCure (ATRC) | United States | $1.454B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
| Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
| Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
| Neogen (NEOG) | United States | $1.090B | 13.94 |
| BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
| InMode (INMD) | Israel | $0.911B | 9.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
| Owens & Minor (OMI) | United States | $0.626B | 5.19 |
| Evolus (EOLS) | United States | $0.617B | 0.00 |
| CeriBell (CBLL) | United States | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.456B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
| Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.273B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
| Omeros (OMER) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
| TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.11 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.14 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |